We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+1.09%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$7.38B
AUM Growth
+$231M
Cap. Flow
+$238M
Cap. Flow %
3.22%
Top 10 Hldgs %
23.76%
Holding
443
New
26
Increased
211
Reduced
155
Closed
11

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$135M
2
PEP icon
PepsiCo
PEP
+$65.3M
3
PNC icon
PNC Financial Services
PNC
+$61.9M
4
HD icon
Home Depot
HD
+$55.7M
5
HAS icon
Hasbro
HAS
+$48M

Top Sells

Rank Stock Value
1
BAX icon
Baxter International
BAX
+$80.6M
2
JNJ icon
Johnson & Johnson
JNJ
+$67.1M
3
USB icon
US Bancorp
USB
+$65.3M
4
MCD icon
McDonald's
MCD
+$50.1M
5
OKE icon
Oneok
OKE
+$49.8M

Sector Composition

Rank Sector Weight
1 Healthcare 16.18%
2 Consumer Staples 15.63%
3 Technology 14.71%
4 Financials 12.61%
5 Industrials 11.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ISIL
326
DELISTED
Intersil Corp
ISIL
$387K 0.01%
27,020
+955
+4% +$14.2K
MET icon
327
MetLife
MET
$62.2B
$384K 0.01%
8,522
+924
+12% +$41.5K
BRS
328
DELISTED
Bristow Group, Inc.
BRS
$378K 0.01%
6,941
+1,960
+39% +$116K
SYT
329
DELISTED
Syngenta Ag
SYT
$378K 0.01%
5,570
+220
+4% +$14.8K
PEGA icon
330
Pegasystems
PEGA
$5.33B
$373K 0.01%
34,248
+1,180
+4% +$12.2K
KUB
331
DELISTED
KUBOTA CORPORATION (ONE ADS REP 5 SHS COM)
KUB
$370K 0.01%
4,680
-20
-0.4% -$1.58K
CMP icon
332
Compass Minerals
CMP
$1.16B
$368K 0.01%
3,950
+290
+8% +$26.5K
TSM icon
333
TSMC
TSM
$2.18T
$368K 0.01%
15,680
+80
+0.5% +$1.88K
TESS
334
DELISTED
Tessco Technologies Inc
TESS
$368K 0.01%
14,920
+355
+2% +$8.65K
CSX icon
335
CSX Corp
CSX
$94.2B
$366K 0.01%
33,180
-9,675
-23% -$111K
LEG icon
336
Leggett & Platt
LEG
$1.32B
$366K 0.01%
7,940
+250
+3% +$11.1K
HRL icon
337
Hormel Foods
HRL
$13.9B
$364K ﹤0.01%
12,800
+2,000
+19% +$54.7K
MATV icon
338
Mativ Holdings
MATV
$693M
$364K ﹤0.01%
7,890
+970
+14% +$42K
NHC icon
339
National Healthcare
NHC
$3.38B
$364K ﹤0.01%
+5,720
New +$363K
SNN icon
340
Smith & Nephew
SNN
$12.6B
$363K ﹤0.01%
10,615
-60
-0.6% -$2.12K
AGN
341
DELISTED
Allergan plc
AGN
$360K ﹤0.01%
+1,209
New +$345K
MJN
342
DELISTED
Mead Johnson Nutrition Company
MJN
$360K ﹤0.01%
3,585
+50
+1% +$5.04K
ANZ
343
DELISTED
AUSTRALIA & NW ZEAL ADS(RP5 SH
ANZ
$356K ﹤0.01%
12,800
+1,050
+9% +$29.2K
YHOO
344
DELISTED
Yahoo Inc
YHOO
$355K ﹤0.01%
8,000
CHRW icon
345
C.H. Robinson
CHRW
$17.5B
$351K ﹤0.01%
4,800
FDN icon
346
First Trust Dow Jones Internet Index Fund ETF
FDN
$5.46B
$351K ﹤0.01%
5,405
-325
-6% -$20.5K
HWCC
347
DELISTED
Houston Wire & Cable Company
HWCC
$349K ﹤0.01%
35,830
+3,345
+10% +$35.7K
JWN
348
DELISTED
Nordstrom
JWN
$348K ﹤0.01%
4,337
+650
+18% +$51.4K
IVV icon
349
iShares Core S&P 500 ETF
IVV
$901B
$346K ﹤0.01%
1,666
+10
+0.6% +$2.08K
K
350
DELISTED
Kellanova
K
$346K ﹤0.01%
5,592

Similar funds

Bahl & Gaynor's Q1 2015 Portfolio in Review

As of Q1 2015, Bahl & Gaynor held 443 positions worth $7.38B, up 3.2% from $7.15B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Bahl & Gaynor deployed $238M of net new capital in Q1 2015, opening 26 new positions and adding to 211 existing holdings. Its largest new stake was Blackstone: 24,777 shares worth $946K.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 17% a quarter earlier, followed by Consumer Staples and Technology.

On the sell side, the largest reduction was Baxter International, an estimated $80.6M trimmed.

  • Bahl & Gaynor's largest Q1 2015 buy was Blackstone: 24,777 shares worth $946K.
  • Bahl & Gaynor added most to Pfizer in Q1 2015, an estimated $135M increase.
  • Bahl & Gaynor's biggest Q1 2015 reduction was Baxter International, cutting an estimated $80.6M.
  • Bahl & Gaynor fully exited MWI VETERINARY SUPPLY, INC. in Q1 2015, selling an estimated $650K.
  • Bahl & Gaynor's ten largest holdings make up 24% of its $7.38B portfolio in Q1 2015.
  • Bahl & Gaynor opened 26 new positions and closed 11 in Q1 2015.
  • Bahl & Gaynor's portfolio value rose 3.2% quarter-over-quarter to $7.38B.

Based on Bahl & Gaynor's 13F filing for Q1 2015, filed 12 May 2015.